Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer–based COVID-19 vaccine ZF2001 in chronic hepatitis B patients

Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer–based COVID-19 vaccine ZF2001 in chronic hepatitis B patients

Background and aimsAlthough COVID-19 vaccination is recommended for the patients with chronic liver disease, the clinical outcomes of COVID-19 vaccinated in patients with chronic hepatitis B (CHB) has not been well characterized. The study aimed to explore the safety and specific antibody responses...

Full description

Bibliographic Details
Main Authors: Shiheng Wu, Xiaolin Wang, Mingyang Feng, Xiaoman Liu, Xinxing Fan, Xiangui Ran, Baogui Wang, Hui Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
COVID-19 vaccine
CHB patients
safety
immunogenicity
ZF2001
CoronaVac
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1078666/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1078666/full

Similar Items